Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Vivos Therapeutics Inc (VVOS)

Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity GlobeNewswire - Mon Jun 22, 7:30AM CDT

LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the...

VVOS : 0.4476 (+3.13%)
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering GlobeNewswire - Thu Jun 11, 7:30AM CDT

LITTLETON, Colo., June 11, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS) , a leading medical device and healthcare services company...

VVOS : 0.4476 (+3.13%)
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients GlobeNewswire - Wed Jun 10, 8:03AM CDT

LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment...

VVOS : 0.4476 (+3.13%)
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026 GlobeNewswire - Mon Jun 8, 12:39PM CDT

LITTLETON, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) , a leading medical device and healthcare services company focused...

VVOS : 0.4476 (+3.13%)
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing GlobeNewswire - Fri Jun 5, 7:45AM CDT

LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS) , a leading medical device and healthcare services company focused...

VVOS : 0.4476 (+3.13%)
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update GlobeNewswire - Wed May 20, 3:10PM CDT

Year-over-year revenue increased 70%, reflecting contribution from Vivos’ acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May...

VVOS : 0.4476 (+3.13%)
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics ACCESS Newswire - Sat Apr 18, 5:00AM CDT

The show also broadcasts as sponsored programming additionally across MENA and Latin America as "Nuevo En La Calle," reaching millions of households worldwide weekly, with expanded digital distribution...

CAST : 7.65 (-12.17%)
NTHI : 4.58 (+1.55%)
ACXP : 1.5200 (+7.04%)
IGC : 0.2630 (+0.42%)
VTIX : 2.79 (-12.26%)
MDCX : 0.4580 (+2.92%)
YYGH : 1.4200 (+11.81%)
DVLT : 0.3342 (-0.68%)
VVOS : 0.4476 (+3.13%)
Vivos Therapeutics Reports Full Year 2025 Financial Results GlobeNewswire - Wed Apr 15, 3:20PM CDT

Full Year 2025 revenue increased 16% Integration of The Sleep Center of Nevada and shift in business model support path to improved revenues, margins and cash flow Management to Host Conference...

VVOS : 0.4476 (+3.13%)
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call GlobeNewswire - Wed Apr 15, 7:45AM CDT

LITTLETON, Colo., April 15, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS) , a leading medical device and healthcare services company focused on the treatment...

VVOS : 0.4476 (+3.13%)
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST) ACCESS Newswire - Sat Apr 11, 7:30AM CDT

The show will air as sponsored programming nationwide at 10:30 PM PST on Fox Business Network

SDST : 1.7000 (+8.97%)
VTIX : 2.79 (-12.26%)
MDCX : 0.4580 (+2.92%)
YYGH : 1.4200 (+11.81%)
VVOS : 0.4476 (+3.13%)

Barchart Exclusives

Cerebras Stock Sold Off After Earnings. Investors Who Panic Sell Are Ignoring the Smart Money. Barchart - 1 hour ago
Investors hit the sell button after earnings, but Morgan Stanley hit the upgrade button. Should panic sellers think twice? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.